Warning: The NCBI web site requires JavaScript to function. more...
Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice.
Thwin MM, Douni E, Arjunan P, Kollias G, Kumar PV, Gopalakrishnakone P.
Arthritis Res Ther. 2009;11(5):R138. Epub 2009 Sep 18.
Related citations
The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion.
Tetlow LC, Woolley DE.
Arthritis Res. 1999;1(1):63-70. Epub 1999 Oct 14.
Retinoblastoma suppression of matrix metalloproteinase 1, but not interleukin-6, through a p38-dependent pathway in rheumatoid arthritis synovial fibroblasts.
Bradley K, Scatizzi JC, Fiore S, Shamiyeh E, Koch AE, Firestein GS, Gorges LL, Kuntsman K, Pope RM, Moore TL, Han J, Perlman H.
Arthritis Rheum. 2004 Jan;50(1):78-87.
Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38.
Hiramitsu T, Yasuda T, Ito H, Shimizu M, Julovi SM, Kakinuma T, Akiyoshi M, Yoshida M, Nakamura T.
Rheumatology (Oxford). 2006 Jul;45(7):824-32. Epub 2006 Jan 31.
Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE, Tetlow LC.
Arthritis Res. 2000;2(1):65-74.
An investigation of cell proliferation and soluble mediators induced by interleukin 1beta in human synovial fibroblasts: comparative response in osteoarthritis and rheumatoid arthritis.
Inoue H, Takamori M, Nagata N, Nishikawa T, Oda H, Yamamoto S, Koshihara Y.
Inflamm Res. 2001 Feb;50(2):65-72.
Suppressive effect of leflunomide metabolite (A77 1726) on metalloproteinase production in IL-1beta stimulated rheumatoid synovial fibroblasts.
Migita K, Miyashita T, Ishibashi H, Maeda Y, Nakamura M, Yatsuhashi H, Ida H, Kawakami A, Aoyagi T, Kawabe Y, Eguchi K.
Clin Exp Immunol. 2004 Sep;137(3):612-6.
Pyrrolidine dithiocarbamate, a NF-kappaB inhibitor, upregulates MMP-1 and MMP-13 in IL-1beta-stimulated rheumatoid arthritis fibroblast-like synoviocytes.
Kim KS, Oh da H, Choi HM, Bang JS, Ryu CJ, Kim JH, Yoo MC, Yang HI.
Eur J Pharmacol. 2009 Jun 24;613(1-3):167-75. Epub 2009 Apr 18.
Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis.
Pakozdi A, Amin MA, Haas CS, Martinez RJ, Haines GK 3rd, Santos LL, Morand EF, David JR, Koch AE.
Arthritis Res Ther. 2006;8(4):R132.
Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis.
Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J.
J Biol Chem. 2000 Jan 7;275(1):444-50.
Modulation of matrix metalloproteinase production by rheumatoid arthritis synovial fibroblasts after cadherin 11 engagement.
Noss EH, Chang SK, Watts GF, Brenner MB.
Arthritis Rheum. 2011 Dec;63(12):3768-78. doi: 10.1002/art.30630.
In vitro model for the analysis of synovial fibroblast-mediated degradation of intact cartilage.
Pretzel D, Pohlers D, Weinert S, Kinne RW.
Arthritis Res Ther. 2009;11(1):R25. Epub 2009 Feb 18.
Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes.
Bidgood MJ, Jamal OS, Cunningham AM, Brooks PM, Scott KF.
J Immunol. 2000 Sep 1;165(5):2790-7.
Suppression of matrix metalloproteinase production from synovial fibroblasts by meloxicam in-vitro.
Asano K, Sakai M, Matsuda T, Tanaka H, Fujii K, Hisamitsu T.
J Pharm Pharmacol. 2006 Mar;58(3):359-66.
Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
Harigai M, Hara M, Kawamoto M, Kawaguchi Y, Sugiura T, Tanaka M, Nakagawa M, Ichida H, Takagi K, Higami-Ohsako S, Shimada K, Kamatani N.
Arthritis Rheum. 2004 Jul;50(7):2167-77.
Triptolide, a novel diterpenoid triepoxide from Tripterygium wilfordii Hook. f., suppresses the production and gene expression of pro-matrix metalloproteinases 1 and 3 and augments those of tissue inhibitors of metalloproteinases 1 and 2 in human synovial fibroblasts.
Lin N, Sato T, Ito A.
Arthritis Rheum. 2001 Sep;44(9):2193-200.
Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections.
Kanangat S, Postlethwaite A, Hasty K, Kang A, Smeltzer M, Appling W, Schaberg D.
Arthritis Res Ther. 2006;8(6):R176.
Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.
Andreakos E, Smith C, Kiriakidis S, Monaco C, de Martin R, Brennan FM, Paleolog E, Feldmann M, Foxwell BM.
Arthritis Rheum. 2003 Jul;48(7):1901-12.
Novel peptide inhibitors of human secretory phospholipase A2 with antiinflammatory activity: solution structure and molecular modeling.
Thwin MM, Satyanarayanajois SD, Nagarajarao LM, Sato K, Arjunan P, Ramapatna SL, Kumar PV, Gopalakrishnakone P.
J Med Chem. 2007 Nov 29;50(24):5938-50. Epub 2007 Nov 1.
Cordycepin inhibits IL-1beta-induced MMP-1 and MMP-3 expression in rheumatoid arthritis synovial fibroblasts.
Noh EM, Kim JS, Hur H, Park BH, Song EK, Han MK, Kwon KB, Yoo WH, Shim IK, Lee SJ, Youn HJ, Lee YR.
Rheumatology (Oxford). 2009 Jan;48(1):45-8.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on